publicações selecionadas
-
artigo de revista
- Impact of cervicovaginal microbiome on the risk of cervical abnormalities development. Journal of Medical Virology. 2023
- Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program. Journal of Medical Virology. 2022
- Association of murine double minute 2 polymorphisms with gastric cancer: A systematic review with meta-analysis. Biomedical Reports. 2021
- The prevalence and risk-factors of oral HPV DNA detection among HIV-infected men between men who have sex with men and heterosexual men. Infectious Diseases. 2021
- Human papillomavirus prevalence and distribution in self-collected samples from female university students in Maputo. International Journal of Gynecology & Obstetrics. 2020
- Estrogen receptors in urogenital schistosomiasis and bladder cancer: Estrogen receptor alpha-mediated cell proliferation. Urologic Oncology: Seminars and Original Investigations. 2020
- Hepatitis E virus in hematopoietic stem cell transplant recipients: A systematic review.. Journal of Clinical Virology. 2019
- High-Risk human papillomavirus genotype distribution in the Northern region of Portugal: Data from regional cervical cancer screening program.. Papillomavirus research (Amsterdam, Netherlands). 2019
- Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications. New Biotechnology. 2019
- Prognostic value of histone marks H3K27me3 and H3K9me3 and modifying enzymes EZH2, SETDB1 and LSD-1 in colorectal cancer.. Journal of cancer research and clinical oncology. 2018
- Glycan affinity magnetic nanoplatforms for urinary glycobiomarkers discovery in bladder cancer.. Talanta. 2018
- Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases.. Urologic oncology. 2017
- Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours.. Molecular oncology. 2017
- Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension.. Oncotarget. 2016
- Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics.. PLOS ONE. 2015
- Stage at presentation of breast cancer in Luanda, Angola - a retrospective study.. BMC Health Services Research. 2015
- The role of functional polymorphisms in immune response genes as biomarkers of bacille Calmette-Guérin (BCG) immunotherapy outcome in bladder cancer: establishment of a predictive profile in a Southern Europe population.. BJU international. 2015
- P53 and cancer-associated sialylated glycans are surrogate markers of cancerization of the bladder associated with Schistosoma haematobium infection.. PLoS neglected tropical diseases. 2014
- The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.. Urologic oncology. 2013
- Personalizing therapies for gastric cancer: molecular mechanisms and novel targeted therapies.. World Journal of Gastroenterology. 2013
- Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy.. British journal of cancer. 2013
- FASL polymorphism is associated with response to bacillus Calmette-Guérin immunotherapy in bladder cancer.. Urologic oncology. 2013
- No significant role for beta tubulin mutations and mismatch repair defects in ovarian cancer resistance to paclitaxel/cisplatin. BMC Cancer. 2005